English
Please Select Search Type
Please Enter Keywords
Search
Please Select Search Type
Please Enter Keywords
Search
English
Current Location:
Reports
Global Bupivacaine Liposome Injection Market Size, Competition Landscape and Supply Chain Research Report 2025

Global Bupivacaine Liposome Injection Market Size, Competition Landscape and Supply Chain Research Report 2025

Published:2025-04-18
Pages:155
Tables and Figures:170
Report ID:WENKH019813
Report Format:
Delivery:48-72h
Select Type ：
Full Report
Competitive Landscape
Select Version ：
Single Users License：$ 3700
Buy Now
Request Sample
Custom Reports
Contact Us
Important Clause:
Recently, our company has discovered that some websites have plagiarized, quoted and modified our original report catalog without authorization, and sold reports under our brand, which has seriously infringed our interests. Therefore, our company recommends that you contact the relevant phone number, email address or leave a message to purchase the report to prevent being deceived.
*All report contents displayed on this website are original to WENKH, and our company has the sole copyright. Any modification, reprinting or quoting in any form is prohibited without our prior written permission. Otherwise, our company reserves the right to pursue legal responsibility.
Research Scope
Table of Contents
Tables and Figures
Full Report

Research Summary

Bupivacaine Liposome Injection is a long-acting local anesthetic formulation that encapsulates bupivacaine, a commonly used pain-relieving drug, in liposomes. These liposomes, which are small lipid-based vesicles, help to gradually release the bupivacaine over an extended period, providing prolonged pain relief compared to traditional bupivacaine injections. This formulation is particularly useful for managing post-surgical pain, as it offers extended anesthesia without the need for repeated doses. Bupivacaine Liposome Injection is typically used in procedures like orthopedic, abdominal, and cardiac surgeries, where prolonged pain management is required. Its controlled release mechanism improves patient comfort by reducing the need for additional analgesics and minimizing the risk of side effects associated with frequent dosing.

According to WENKH research statistics, the global Bupivacaine Liposome Injection market size will reach 633.47 Million USD in 2025 and is projected to reach 1,151.33 Million USD by 2032, with a CAGR of 8.91% (2025-2032). Among them, the Asia-Pacific Bupivacaine Liposome Injection market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.

The global Bupivacaine Liposome Injection market is highly competitive, with key market players including Pacira Pharmaceuticals, Jiangsu Hengrui Pharma, etc. This report categorizes the competitive landscape of the global Bupivacaine Liposome Injection market into three tiers based on annual revenue, with the top three market players holding approximately  % of the total market share.

This report provides an in-depth analysis of the global Bupivacaine Liposome Injection market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, revenue, sales volume and gross profit margin of major manufacturers in the global Bupivacaine Liposome Injection industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different segments of Bupivacaine Liposome Injection and their downstream application fields.

In terms of data coverage, this report includes extensive time-series data. Historical data spans from 2020 to 2024, providing a solid foundation for analyzing market development trends. The year 2025 is used as a base year to accurately assess the current market landscape, while forecast data extends from 2026 to 2032, using scientific analysis methods and models to offer forward-looking projections and insights into the market's future trajectory. This provides valuable reference information for industry participants and stakeholders.

The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the revenue and sales volume of Bupivacaine Liposome Injection in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Bupivacaine Liposome Injection market. By considering local policies, this report evaluates the market prospects of Bupivacaine Liposome Injection in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places significant emphasis on data quality and reliability, leveraging a wide range of data sources to ensure accuracy and validity. Primary data collection is conducted through multiple channels, including in-depth interviews with senior corporate executives, industry experts, supply chain participants, and end consumers. This helps to gain insights into corporate strategic planning, industry policies, supply chain dynamics, and user experiences. Secondary data sources cover an extensive range, including authoritative government statistics, customs databases, industry related reports, third-party paid databases, investment research reports, academic studies, corporate financial statements, real-time media updates, and information from international organizations, all of which serve as a solid foundation for data verification and analysis.

Companies Covered

Pacira Pharmaceuticals

Jiangsu Hengrui Pharma

Product Segment

133mg per Vial

266mg per Vial

Product Application

Hospital

Clinic


Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global Bupivacaine Liposome Injection Industry Chain Analysis

Chapter 3: Global Bupivacaine Liposome Injection Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Bupivacaine Liposome Injection Market (Market Share, Product Revenue and Sales Volume Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Sales Volume, Product Average Price, Product Gross Profit Margin and Geographical Sales Share)

Chapter 6: Global Bupivacaine Liposome Injection Product Segment, Downstream Application and Major Regional Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 7: North America Bupivacaine Liposome Injection Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 8: Europe Bupivacaine Liposome Injection Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 9: China Bupivacaine Liposome Injection Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 10: Asia Pacific (excluding China) Bupivacaine Liposome Injection Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 11: Latin America Bupivacaine Liposome Injection Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 12: Middle East and Africa Bupivacaine Liposome Injection Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 13: Research Conclusion

Chapter 14: Methodology and Data Source


Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.

Table of Content

1 Bupivacaine Liposome Injection Market Overview

   1.1 Product Definition Introduction

   1.2 Global Bupivacaine Liposome Injection Market Size and Growth Forecast Analysis (2020-2032)

   1.3 Bupivacaine Liposome Injection Market Status and Development Prospects

       1.3.1 Bupivacaine Liposome Injection Market Status

       1.3.2 Bupivacaine Liposome Injection Industry Development Prospects

   1.4 Bupivacaine Liposome Injection Market Overview by Product Segment

       1.4.1 Global Bupivacaine Liposome Injection Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032

       1.4.2 133mg per Vial

       1.4.3 266mg per Vial

   1.5 Bupivacaine Liposome Injection Market Overview by Product Application

       1.5.1 Global Bupivacaine Liposome Injection Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032

       1.5.2 Hospital

       1.5.3 Clinic

2 Bupivacaine Liposome Injection Industry Supply Chain Analysis

   2.1 Bupivacaine Liposome Injection Supply Chain

   2.2 Bupivacaine Liposome Injection Industry Upstream Supply Analysis

       2.2.1 Upstream Raw Materials Supply Status

       2.2.2 Key Raw Material Suppliers

   2.3 Bupivacaine Liposome Injection Midstream Manufacturers

   2.4 Bupivacaine Liposome Injection Downstream Customers

   2.5 Bupivacaine Liposome Injection Sales Channel Analysis

3 Bupivacaine Liposome Injection Market Environment Analysis

   3.1 Bupivacaine Liposome Injection Industry Policy Analysis

   3.2 Bupivacaine Liposome Injection Emerging Technology Trends in the Industry

   3.3 Bupivacaine Liposome Injection Restraining Factors Analysis

   3.4 Bupivacaine Liposome Injection Market Porter's Five Forces Analysis

       3.4.1 Competitive Rivalry

       3.4.2 Threat of New Entrants

       3.4.3 Bargaining Power of Suppliers

       3.4.4 Bargaining Power of Buyers

       3.4.5 Threat of Substitute Products or Services

4 Global Bupivacaine Liposome Injection Manufacturer Competition Landscape

   4.1 Global Bupivacaine Liposome Injection Market Sales Volume, Revenue by Key Manufacturers (2021-2025)

       4.1.1 Global Bupivacaine Liposome Injection Market Sales Volume by Key Manufacturers (2021-2025)

       4.1.2 Global Bupivacaine Liposome Injection Market Revenue by Key Manufacturers (2021-2025)

   4.2 Global Bupivacaine Liposome Injection Market Position by Key Manufacturers

   4.3 China Bupivacaine Liposome Injection Market Position by Key Manufacturers

   4.4 Global Key Manufacturers Headquarter and Key Area Served

   4.5 Global Bupivacaine Liposome Injection Market Expansion and M&A Dynamic

5 In-depth Analysis of Key Players

   5.1 Pacira Pharmaceuticals

       5.1.1 Pacira Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.1.2 Pacira Pharmaceuticals Bupivacaine Liposome Injection Product Features

       5.1.3 Pacira Pharmaceuticals Bupivacaine Liposome Injection Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.1.4 Pacira Pharmaceuticals Bupivacaine Liposome Injection Revenue by Product Segment

       5.1.5 Pacira Pharmaceuticals Bupivacaine Liposome Injection Revenue by Region

   5.2 Jiangsu Hengrui Pharma

       5.2.1 Jiangsu Hengrui Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.2.2 Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Product Features

       5.2.3 Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.2.4 Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Revenue by Product Segment

       5.2.5 Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Revenue by Region

6 Global Bupivacaine Liposome Injection Market Analysis by Regions, by Product Segment and Application

   6.1 Global Bupivacaine Liposome Injection Market Size and Growth Forecast by Region: 2020 VS 2025 VS 2032

       6.1.1 Global Bupivacaine Liposome Injection Market Revenue by Region (2020-2025)

       6.1.2 Global Bupivacaine Liposome Injection Market Revenue Forecast by Region (2026-2032)

   6.2 Global Bupivacaine Liposome Injection Market Sales Volume Analysis

       6.2.1 Global Bupivacaine Liposome Injection Market Sales Volume by Region (2020-2025)

       6.2.2 Global Bupivacaine Liposome Injection Market Sales Volume Forecast by Region (2026-2032)

   6.3 Global Bupivacaine Liposome Injection Market by Product Segment (2020-2032)

       6.3.1 Global Bupivacaine Liposome Injection Market Revenue and Forecast by Product Segment

       6.3.2 Global Bupivacaine Liposome Injection Market Sales Volume and Forecast by Product Segment

   6.4 Global Bupivacaine Liposome Injection Market by Product Application (2020-2032)

       6.4.1 Global Bupivacaine Liposome Injection Market Revenue and Forecast by Product Application

       6.4.2 Global Bupivacaine Liposome Injection Market Sales Volume and Forecast by Product Application

7 North America Bupivacaine Liposome Injection Market Analysis

   7.1 North America Bupivacaine Liposome Injection Market Prospects

       7.1.1 North America Bupivacaine Liposome Injection Market Revenue and Growth Forecast by Countries (2020-2032)

       7.1.2 North America Bupivacaine Liposome Injection Sales Volume and Growth Forecast by Countries (2020-2032)

       7.1.3 U.S.

       7.1.4 Canada

   7.2 North America Bupivacaine Liposome Injection Market by Product Segment (2020-2032)

       7.2.1 North America Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Segment

       7.2.2 North America Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Segment

   7.3 North America Bupivacaine Liposome Injection Market by Product Application (2020-2032)

       7.3.1 North America Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Application

       7.3.2 North America Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Application

8 Europe Bupivacaine Liposome Injection Market Analysis

   8.1 Europe Bupivacaine Liposome Injection Market Prospects

       8.1.1 Europe Bupivacaine Liposome Injection Market Revenue and Growth Forecast by Countries (2020-2032)

       8.1.2 Europe Bupivacaine Liposome Injection Sales Volume and Growth Forecast by Countries (2020-2032)

       8.1.3 Germany

       8.1.4 France

       8.1.5 United Kingdom

       8.1.6 Italy

       8.1.7 Spain

       8.1.8 Benelux

   8.2 Europe Bupivacaine Liposome Injection Market by Product Segment (2020-2032)

       8.2.1 Europe Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Segment

       8.2.2 Europe Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Segment

   8.3 Europe Bupivacaine Liposome Injection Market by Product Application (2020-2032)

       8.3.1 Europe Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Application

       8.3.2 Europe Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Application

9 China Bupivacaine Liposome Injection Market Analysis

   9.1 China Bupivacaine Liposome Injection Market Prospects

       9.1.1 China Bupivacaine Liposome Injection Revenue and Growth Forecast (2020-2032)

       9.1.2 China Bupivacaine Liposome Injection Market Sales Volume and Growth Forecast (2020-2032)

   9.2 China Bupivacaine Liposome Injection Market by Product Segment (2020-2032)

       9.2.1 China Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Segment

       9.2.2 China Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Segment

   9.3 China Bupivacaine Liposome Injection Market by Product Application (2020-2032)

       9.3.1 China Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Application

       9.3.2 China Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Application

10 Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Analysis

   10.1 Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Prospects

       10.1.1 Asia Pacific (excl. China) Bupivacaine Liposome Injection Revenue and Growth Forecast by Countries (2020-2032)

       10.1.2 Asia Pacific (excl. China) Bupivacaine Liposome Injection Sales Volume and Growth Forecast by Countries (2020-2032)

       10.1.3 Japan

       10.1.4 South Korea

       10.1.5 India

       10.1.6 Southeast Asia

       10.1.7 Australia

   10.2 Asia Pacific (excl. China) Bupivacaine Liposome Injection Market by Product Segment (2020-2032)

       10.2.1 Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Segment

       10.2.2 Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Segment

   10.3 Asia Pacific (excl. China) Bupivacaine Liposome Injection Market by Product Application (2020-2032)

       10.3.1 Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Application

       10.3.2 Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Application

11 Latin America Bupivacaine Liposome Injection Market Analysis

   11.1 Latin America Bupivacaine Liposome Injection Market Prospects

       11.1.1 Latin America Bupivacaine Liposome Injection Revenue and Growth Forecast by Countries (2020-2032)

       11.1.2 Latin America Bupivacaine Liposome Injection Sales Volume and Growth Forecast by Countries (2020-2032)

       11.1.3 Mexico

       11.1.4 Brazil

   11.2 Latin America Bupivacaine Liposome Injection Market by Product Segment (2020-2032)

       11.2.1 Latin America Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Segment

       11.2.2 Latin America Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Segment

   11.3 Latin America Bupivacaine Liposome Injection Market by Product Application (2020-2032)

       11.3.1 Latin America Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Application

       11.3.2 Latin America Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Application

12 Middle East and Africa Bupivacaine Liposome Injection Market Analysis

   12.1 Middle East and Africa Bupivacaine Liposome Injection Market Prospects

       12.1.1 Middle East and Africa Bupivacaine Liposome Injection Revenue and Growth Forecast by Countries (2020-2032)

       12.1.2 Middle East and Africa Bupivacaine Liposome Injection Sales Volume and Growth Forecast by Countries (2020-2032)

       12.1.3 Saudi Arabia

       12.1.4 South Africa

   12.2 Middle East and Africa Bupivacaine Liposome Injection Market by Product Segment (2020-2032)

       12.2.1 Middle East and Africa Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Segment

       12.2.2 Middle East and Africa Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Segment

   12.3 Middle East and Africa Bupivacaine Liposome Injection Market by Product Application (2020-2032)

       12.3.1 Middle East and Africa Bupivacaine Liposome Injection Market Revenue and Forecast Analysis by Product Application

       12.3.2 Middle East and Africa Bupivacaine Liposome Injection Market Sales Volume and Forecast Analysis by Product Application

13 Research Conclusion

14 Appendix

   14.1 Methodology/Research Approach

   14.2 Research Landscape

   14.3 Research Benchmark and Hypothesis

   14.4 Data Source

       14.4.1 Primary Sources

       14.4.2 Secondary Sources

   14.5 Data Cross Validation

   14.6 Disclaimer

image.png

Table 1：Global Bupivacaine Liposome Injection Product Segment Market Size and Growth Forecast Analysis (2020 VS 2025 VS 2032) & (Million USD)

Table 2：Global Bupivacaine Liposome Injection Market Size and Growth Forecast Analysis by Application (2020 VS 2025 VS 2032) & (Million USD)

Table 3：Key Raw Materials and Market Concentration

Table 4：Bupivacaine Liposome Injection Raw Material Suppliers and Contact Information

Table 5：Bupivacaine Liposome Injection Downstream Customers List

Table 6：Bupivacaine Liposome Injection Distributors/Dealers List

Table 7：Global Bupivacaine Liposome Injection Market Sales Volume by Key Manufacturers (2021-2025) & (K Doses)

Table 8：Global Bupivacaine Liposome Injection Market Revenue by Key Manufacturers (2021-2025) & (Million USD)

Table 9：Global Bupivacaine Liposome Injection Market Position by Key Manufacturers

Table 10：China Bupivacaine Liposome Injection Market Position by Key Manufacturers

Table 11：Global Key Manufacturers Headquarter and Key Area Served

Table 12：Global Bupivacaine Liposome Injection Market Expansion and M&A Dynamic

Table 13：Pacira Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 14：Pacira Pharmaceuticals Bupivacaine Liposome Injection Product Features

Table 15：Pacira Pharmaceuticals Bupivacaine Liposome Injection Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 16：Pacira Pharmaceuticals Bupivacaine Liposome Injection Revenue by Product Segment

Table 17：Pacira Pharmaceuticals Bupivacaine Liposome Injection Revenue by Region

Table 18：Jiangsu Hengrui Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 19：Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Product Features

Table 20：Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 21：Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Revenue by Product Segment

Table 22：Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Revenue by Region

Table 23：Global Bupivacaine Liposome Injection Market Size and Growth Forecast by Region (2020 VS 2025 VS 2032) & (Million USD)

Table 24：Global Bupivacaine Liposome Injection Market Revenue by Region (2020-2025) & (Million USD)

Table 25：Global Bupivacaine Liposome Injection Market Share by Region (2020-2025)

Table 26：Global Bupivacaine Liposome Injection Market Revenue Forecast by Region (2026-2032) & (Million USD)

Table 27：Global Bupivacaine Liposome Injection Market Share Forecast by Region (2026-2032)

Table 28：Global Bupivacaine Liposome Injection Market Sales by Region (2020-2025) & (K Doses)

Table 29：Global Bupivacaine Liposome Injection Sales Volume Market Share by Region (2020-2025)

Table 30：Global Bupivacaine Liposome Injection Market Sales Volume Forecast by Region (2026-2032) & (K Doses)

Table 31：Global Bupivacaine Liposome Injection Sales Volume Market Share Forecast by Region (2026-2032)

Table 32：Global Bupivacaine Liposome Injection Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 33：Global Bupivacaine Liposome Injection Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 34：Global Bupivacaine Liposome Injection Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 35：Global Bupivacaine Liposome Injection Market Sales Volume Forecast by Product Segment (2026-2032) & (K Doses)

Table 36：Global Bupivacaine Liposome Injection Market Revenue by Product Application (2020-2025) & (Million USD)

Table 37：Global Bupivacaine Liposome Injection Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 38：Global Bupivacaine Liposome Injection Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 39：Global Bupivacaine Liposome Injection Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 40：North America Bupivacaine Liposome Injection Market Revenue by Countries (2020-2025) & (Million USD)

Table 41：North AmericaBupivacaine Liposome Injection Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 42：North America Bupivacaine Liposome Injection Market Sales Volume by Countries (2020-2025) & K Doses)

Table 43：North America Bupivacaine Liposome Injection Market Sales Volume Forecast by Countries (2026-2032) & (K Doses)

Table 44：North America Bupivacaine Liposome Injection Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 45：North America Bupivacaine Liposome Injection Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 46：North America Bupivacaine Liposome Injection Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 47：North America Bupivacaine Liposome Injection Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 48：North America Bupivacaine Liposome Injection Market Revenue by Product Application (2020-2025) & (Million USD)

Table 49：North America Bupivacaine Liposome Injection Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 50：North America Bupivacaine Liposome Injection Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 51：North America Bupivacaine Liposome Injection Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 52：Europe Bupivacaine Liposome Injection Market Revenue by Countries (2020-2025) & (Million USD)

Table 53：Europe Bupivacaine Liposome Injection Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 54：Europe Bupivacaine Liposome Injection Market Sales Volume by Countries (2020-2025) & (K Doses)

Table 55：Europe Bupivacaine Liposome Injection Market Sales Volume Forecast by Countries (2026-2032) & (K Doses)

Table 56：Europe Bupivacaine Liposome Injection Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 57：Europe Bupivacaine Liposome Injection Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 58：Europe Bupivacaine Liposome Injection Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 59：Europe Bupivacaine Liposome Injection Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 60：Europe Bupivacaine Liposome Injection Market Revenue by Product Application (2020-2025) & (Million USD)

Table 61：Europe Bupivacaine Liposome Injection Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 62：Europe Bupivacaine Liposome Injection Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 63：Europe Bupivacaine Liposome Injection Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 64：China Bupivacaine Liposome Injection Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 65：China Bupivacaine Liposome Injection Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 66：China Bupivacaine Liposome Injection Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 67：China Bupivacaine Liposome Injection Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 68：China Bupivacaine Liposome Injection Market Revenue by Product Application (2020-2025) & (Million USD)

Table 69：China Bupivacaine Liposome Injection Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 70：China Bupivacaine Liposome Injection Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 71：China Bupivacaine Liposome Injection Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 72：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Revenue by Countries (2020-2025) & (Million USD)

Table 73：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 74：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Sales Volume by Countries (2020-2025) & (K Doses)

Table 75：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Sales Volume Forecast by Countries (2026-2032) & (K Doses)

Table 76：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 77：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 78：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 79：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 80：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Revenue by Product Application (2020-2025) & (Million USD)

Table 81：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 82：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 83：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 84：Latin America Bupivacaine Liposome Injection Market Revenue by Countries (2020-2025) & (Million USD)

Table 85：Latin America Bupivacaine Liposome Injection Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 86：Latin America Bupivacaine Liposome Injection Market Sales Volume by Countries (2020-2025) & (K Doses)

Table 87：Latin America Bupivacaine Liposome Injection Market Sales Volume Forecast by Countries (2026-2032) & (K Doses)

Table 88：Latin America Bupivacaine Liposome Injection Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 89：Latin America Bupivacaine Liposome Injection Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 90：Latin America Bupivacaine Liposome Injection Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 91：Latin America Bupivacaine Liposome Injection Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 92：Latin America Bupivacaine Liposome Injection Market Revenue by Product Application (2020-2025) & (Million USD)

Table 93：Latin America Bupivacaine Liposome Injection Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 94：Latin America Bupivacaine Liposome Injection Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 95：Latin America Bupivacaine Liposome Injection Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 96：Middle East and Africa Bupivacaine Liposome Injection Market Revenue by Countries (2020-2025) & (Million USD)

Table 97：Middle East and Africa Bupivacaine Liposome Injection Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 98：Middle East and Africa Bupivacaine Liposome Injection Market Sales Volume by Countries (2020-2025) & (K Doses)

Table 99：Middle East and Africa Bupivacaine Liposome Injection Market Sales Volume Forecast by Countries (2026-2032) & (K Doses)

Table 100：Middle East and Africa Bupivacaine Liposome Injection Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 101：Middle East and Africa Bupivacaine Liposome Injection Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 102：Middle East and Africa Bupivacaine Liposome Injection Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 103：Middle East and Africa Bupivacaine Liposome Injection Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 104：Middle East and Africa Bupivacaine Liposome Injection Market Revenue by Product Application (2020-2025) & (Million USD)

Table 105：Middle East and Africa Bupivacaine Liposome Injection Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 106：Middle East and Africa Bupivacaine Liposome Injection Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 107：Middle East and Africa Bupivacaine Liposome Injection Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 108：Secondary Sources


image.png

Figure 1：Bupivacaine Liposome Injection Product Scope

Figure 2：Global Bupivacaine Liposome Injection Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)

Figure 3：Global Bupivacaine Liposome Injection Sales Volume and Growth Forecast Analysis (2020-2032) & (K Doses)

Figure 4：Global Bupivacaine Liposome Injection Product Segment Market Share (2025 & 2032)

Figure 5：Global Bupivacaine Liposome Injection Product Application Market Share (2025 & 2032)

Figure 6：133mg per Vial Product Scope

Figure 7：266mg per Vial Product Scope

Figure 8：Hospital Product Scope

Figure 9：Clinic Product Scope

Figure 10：Bupivacaine Liposome Injection Industrial Chain Framework

Figure 11：Global Bupivacaine Liposome Injection Market by Geographic Segmentation in 2025

Figure 12：Global Bupivacaine Liposome Injection Market Share by Region (2020 VS 2025)

Figure 13：Global Bupivacaine Liposome Injection Sales Volume Market Share by Region (2020 VS 2025)

Figure 14：North America Bupivacaine Liposome Injection Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 15：North America Bupivacaine Liposome Injection Revenue Market Share by Countries (2025 VS 2032)

Figure 16：North America Bupivacaine Liposome Injection Sales Volume Market Share by Countries (2025 VS 2032)

Figure 17：U.S. Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 18：U.S. Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 19：Canada Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 20：Canada Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 21：Europe Bupivacaine Liposome Injection Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 22：Europe Bupivacaine Liposome Injection Revenue Market Share by Countries (2025 VS 2032)

Figure 23：Europe Bupivacaine Liposome Injection Sales Volume Market Share by Countries (2025 VS 2032)

Figure 24：Germany Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 25：Germany Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 26：France Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 27：France Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 28：United Kingdom Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 29：United Kingdom Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 30：Italy Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 31：Italy Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 32：Spain Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 33：Spain Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 34：Benelux Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 35：Benelux Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 36：China Bupivacaine Liposome Injection Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 37：China Bupivacaine Liposome Injection Market Sales Volume and Growth Forecast (K Doses)

Figure 38：Asia Pacific (excl. China) Bupivacaine Liposome Injection Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 39：Asia Pacific (excl. China) Bupivacaine Liposome Injection Revenue Market Share by Countries (2025 VS 2032)

Figure 40：Asia Pacific (excl. China) Bupivacaine Liposome Injection Sales Volume Market Share by Countries (2025 VS 2032)

Figure 41：Japan Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 42：Japan Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 43：South Korea Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 44：South Korea Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 45：India Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 46：India Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 47：Southeast Asia Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 48：Southeast Asia Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 49：Australia Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 50：Australia Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 51：Latin America Bupivacaine Liposome Injection Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 52：Latin America Bupivacaine Liposome Injection Revenue Market Share by Countries (2025 VS 2032)

Figure 53：Latin America Bupivacaine Liposome Injection Sales Volume Market Share by Countries (2025 VS 2032)

Figure 54：Mexico Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 55：Mexico Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 56：Brazil Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 57：Brazil Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 58：Middle East and Africa Bupivacaine Liposome Injection Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 59：Middle East and Africa Bupivacaine Liposome Injection Revenue Market Share by Countries (2025 VS 2032)

Figure 60：Middle East and Africa Bupivacaine Liposome Injection Sales Volume Market Share by Countries (2025 VS 2032)

Figure 61：Saudi Arabia Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 62：Saudi Arabia Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 63：South Africa Bupivacaine Liposome Injection Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 64：South Africa Bupivacaine Liposome Injection Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 65：Research Methodology

Figure 66：Primary Sources

Figure 67：Data Cross Validation

Global Bupivacaine Liposome Injection Revenue and Market Share by Key Players

Revenue (US$ Million)20202021202220232024
Pacira PharmaceuticalsXXXXXXXXXX
Jiangsu Hengrui PharmaXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


Global Bupivacaine Liposome Injection Sales Volume and Market Share by Key Players

Sales (K Doses)20202021202220232024
Pacira PharmaceuticalsXXXXXXXXXX
Jiangsu Hengrui PharmaXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


Related Reports

Global Healthcare Supply Chain Managements Market Competitors, Segment Types and Downstream Applications Research Report 2025

2025-04-10

Global Healthcare Supply Chain Managements Market Size, Competition Landscape and Supply Chain Research Report 2025

2025-04-10

Global Hemodialysis and Peritoneal Dialysis Market Competitors, Segment Types and Downstream Applications Research Report 2025

2025-04-10

Global Hemodialysis and Peritoneal Dialysis Market Size, Competition Landscape and Supply Chain Research Report 2025

2025-04-10

Global Pharmaceutical CDMO Market Competitors, Segment Types and Downstream Applications Research Report 2025

2025-04-10

Global Pharmaceutical CDMO Market Size, Competition Landscape and Supply Chain Research Report 2025

2025-04-10

Global Full-Service Clinical Research Organization (CRO) Market Competitors, Segment Types and Downstream Applications Research Report 2025

2025-04-10

Global Full-Service Clinical Research Organization (CRO) Market Size, Competition Landscape and Supply Chain Research Report 2025

2025-04-10
How to Order
Contact
Fill in your contact information, and the company will quickly match the specialist to get in touch with you
You can also directly call our customer service hotline or add customer service WeChat
Samples
One on one business specialist will send the complete version of the sample
If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples
Payment
Both parties sign a report purchase contract
Support Paypal, Visa, UnionPay and MasterCard Payment
Delivery
PDF report (sent online 2-3 working days after payment)
WORD version report (sent online 2-3 working days after payment)
Paper version report (sent via EMS or DHL within 3-5 working days after payment)
After-Sales
Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied
No Relevant Report Found? Please Contact Us
Custom Reports
WENKH is a global leading consulting brand for industry segments. We provide segmented market research reports, custom research, white papers and feasibility reports for all industries, focusing on market status and forecasts, competition analysis, market prospects analysis and market positioning. WENKH uses professional data and deep insights to help companies make decisions and promote win-win cooperation.
About WENKH
Home
Reports
Custom Research
Industry News
About Us
Contact
Contact Us
Ocean Tower, No.145, Hong Kong Road, Wuhan City, Hube Province, China
Copyright © WENKH.com All rights reserved.